The Role of Efferocytosis in Atherosclerosis

Circulation

Volumn 135, Issue 5, 2017, Pages 476-489

  Kojima, Yoko ^a   Weissman, Irving L ^b   Leeper, Nicholas J ^c,d  

^a Division of Vascular Surgery   (United States)

^b Institute for Stem Cell Biology and Regenerative   (United States)

^c Division of Cardiovascular Medicine   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

atherosclerosis; efferocytosis; macrophage; necrotic core; vascular biology

Indexed keywords

CALRETICULIN; CD47 ANTIGEN; LACTADHERIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MER RECEPTOR TYROSINE KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; EFFEROCYTOSIS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSLATION REGULATION; VASCULAR DISEASE; MACROPHAGE; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY;

APOPTOSIS; ATHEROSCLEROSIS; HUMANS; MACROPHAGES; PHAGOCYTOSIS;

EID: 85012040926     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.025684     Document Type: Article

References (100)

1. Kinchen JM, Ravichandran KS, Phagocytic signaling: you can touch, but you can't eat. Curr Biol 2008 18 R521 R524. doi: 10.1016/j.cub.2008.04.058.
2. Thorp EB, Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease. Apoptosis 2010 15 1124 1136. doi: 10.1007/s10495-010-0516-6.
3. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992 148 2207 2216
4. Ravichandran KS, Lorenz U, Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007 7 964 974. doi: 10.1038/nri2214.
5. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA, Henson PM, Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 2001 155 649 659. doi: 10.1083/jcb.200108080.
6. Thorp E, Tabas I, Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol 2009 86 1089 1095. doi: 10.1189/jlb.0209115.
7. deCathelineau AM, Henson PM, The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 2003 39 105 117
8. Tabas I, Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010 10 36 46. doi: 10.1038/nri2675.
9. Savill J, Dransfield I, Gregory C, Haslett C, A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002 2 965 975. doi: 10.1038/nri957.
10. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM, Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-Activation of LRP on the phagocyte. Cell 2005 123 321 334. doi: 10.1016/j.cell.2005.08.032.
11. Henson PM, Bratton DL, Fadok VA, Apoptotic cell removal. Curr Biol 2001 11 R795 R805
12. Ravichandran KS, Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med 2010 207 1807 1817. doi: 10.1084/jem.20101157.
13. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W, Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 2005 25 1256 1261. doi: 10.1161/01.ATV.0000166517.18801.a7.
14. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R, Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010 30 1282 1292. doi: 10.1161/ATVBAHA.108.179739.
15. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R, Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000 157 1259 1268. doi: 10.1016/S0002-9440(10)64641-X.
16. Martinet W, Schrijvers DM, De Meyer GR, Necrotic cell death in atherosclerosis. Basic Res Cardiol 2011 106 749 760. doi: 10.1007/s00395-011-0192-x.
17. Tabas I, Pulling down the plug on atherosclerosis: finding the culprit in your heart. Nat Med 2011 17 791 793. doi: 10.1038/nm0711-791.
18. Kiss RS, Elliott MR, Ma Z, Marcel YL, Ravichandran KS, Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. Curr Biol 2006 16 2252 2258. doi: 10.1016/j.cub.2006.09.043.
19. Kojima Y, Downing K, Kundu R, Miller C, Dewey F, Lancero H, Raaz U, Perisic L, Hedin U, Schadt E, Maegdefessel L, Quertermous T, Leeper NJ, Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest 2014 124 1083 1097. doi: 10.1172/JCI70391.
20. Moore KJ, Tabas I, Macrophages in the pathogenesis of atherosclerosis. Cell 2011 145 341 355. doi: 10.1016/j.cell.2011.04.005.
21. Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR, Tabas I, Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 2007 82 1040 1050. doi: 10.1189/jlb.0307192.
22. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998 101 890 898. doi: 10.1172/JCI1112.
23. Schrijvers DM, De Meyer GR, Herman AG, Martinet W, Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007 73 470 480. doi: 10.1016/j.cardiores.2006.09.005.
24. Ravichandran KS, Beginnings of a good apoptotic meal: The find-me and eat-me signaling pathways. Immunity 2011 35 445 455. doi: 10.1016/j.immuni.2011.09.004.
25. Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A, Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation 1999 99 348 353
26. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG, Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998 97 2307 2315
27. Liu J, Thewke DP, Su YR, Linton MF, Fazio S, Sinensky MS, Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 2005 25 174 179. doi: 10.1161/01.ATV.0000148548.47755.22.
28. Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A, Bookout AL, Mak PA, Edwards PA, Mangelsdorf DJ, Tontonoz P, Miyazaki T, A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 2005 1 201 213. doi: 10.1016/j.cmet.2005.02.002.
29. Gautier EL, Huby T, Witztum JL, Ouzilleau B, Miller ER, Saint-Charles F, Aucouturier P, Chapman MJ, Lesnik P, Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009 119 1795 1804. doi: 10.1161/CIRCULATIONAHA.108.806158.
30. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR, Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006 12 1075 1080. doi: 10.1038/nm1459.
31. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V, Macrophage polarization by angiotensin II-Type 1 receptor aggravates renal injury-Acceleration of atherosclerosis. Arterioscler Thromb Vasc Biol 2011 31 2856 2864. doi: 10.1161/ATVBAHA.111.237198.
32. Martinez FO, Helming L, Gordon S, Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009 27 451 483. doi: 10.1146/annurev.immunol.021908.132532.
33. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N, Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998 188 1359 1368
34. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S, Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007 178 6912 6922
35. Li Y, Gerbod-Giannone MC, Seitz H, Cui D, Thorp E, Tall AR, Matsushima GK, Tabas I, Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J Biol Chem 2006 281 6707 6717. doi: 10.1074/jbc.M510579200.
36. Van Vré EA, Ait-Oufella H, Tedgui A, Mallat Z, Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler Thromb Vasc Biol 2012 32 887 893. doi: 10.1161/ATVBAHA.111.224873.
37. Clarke MC, Talib S, Figg NL, Bennett MR, Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res 2010 106 363 372. doi: 10.1161/CIRCRESAHA.109.208389.
38. Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJ, Blankensteijn JD, Ronkainen A, Jääskeläinen JE, Kyo Y, Lenk GM, Sakalihasan N, Kostulas K, Gottsäter A, Flex A, Stefansson H, Hansen T, Andersen G, Weinsheimer S, Borch-Johnsen K, Jorgensen T, Shah SH, Quyyumi AA, Granger CB, Reilly MP, Austin H, Levey AI, Vaccarino V, Palsdottir E, Walters GB, Jonsdottir T, Snorradottir S, Magnusdottir D, Gudmundsson G, Ferrell RE, Sveinbjornsdottir S, Hernesniemi J, Niemelä M, Limet R, Andersen K, Sigurdsson G, Benediktsson R, Verhoeven EL, Teijink JA, Grobbee DE, Rader DJ, Collier DA, Pedersen O, Pola R, Hillert J, Lindblad B, Valdimarsson EM, Magnadottir HB, Wijmenga C, Tromp G, Baas AF, Ruigrok YM, van Rij AM, Kuivaniemi H, Powell JT, Matthiasson SE, Gulcher JR, Thorgeirsson G, Kong A, Thorsteinsdottir U, Stefansson K, The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008 40 217 224. doi: 10.1038/ng.72.
39. Nanda V, Downing KP, Ye J, Xiao S, Kojima Y, Spin JM, DiRenzo D, Nead KT, Connolly AJ, Dandona S, Perisic L, Hedin U, Maegdefessel L, Dalman J, Guo L, Zhao X, Kolodgie FD, Virmani R, Davis HR Jr, Leeper NJ, CDKN2B regulates TGFβ signaling and smooth muscle cell investment of hypoxic neovessels. Circ Res 2016 118 230 240. doi: 10.1161/CIRCRESAHA.115.307906.
40. Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, Miller CL, Roberts SC, Spin JM, de Almeida PE, Wu JC, Xu B, Cheng K, Quertermous M, Kundu S, Kortekaas KE, Berzin E, Downing KP, Dalman RL, Tsao PS, Schadt EE, Owens GK, Quertermous T, Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol 2013 33 e1 e10. doi: 10.1161/ATVBAHA.112.300399.
41. Cunnington MS, Keavney B, Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus. Curr Atheroscler Rep 2011 13 193 201. doi: 10.1007/s11883-011-0178-z.
42. Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ, CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 2016 536 86 90. doi: 10.1038/nature18935.
43. Komura H, Miksa M, Wu R, Goyert SM, Wang P, Milk fat globule epidermal growth factor-factor VIII is down-regulated in sepsis via the lipopolysaccharide-CD14 pathway. J Immunol 2009 182 581 587
44. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK, A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007 109 1026 1033. doi: 10.1182/blood-2006-05-021634.
45. Thorp E, Subramanian M, Tabas I, The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 2011 41 2515 2518. doi: 10.1002/eji.201141719.
46. Libby P, Inflammation in atherosclerosis. Nature 2002 420 868 874. doi: 10.1038/nature01323.
47. Chang MK, Bergmark C, Laurila A, Hörkkö S, Han KH, Friedman P, Dennis EA, Witztum JL, Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 1999 96 6353 6358
48. Shaw PX, Hörkkö S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL, Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 2001 21 1333 1339
49. Aprahamian T, Takemura Y, Goukassian D, Walsh K, Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol 2008 152 448 455. doi: 10.1111/j.1365-2249.2008.03658.x.
50. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I, Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/-mice. Arterioscler Thromb Vasc Biol 2008 28 1421 1428. doi: 10.1161/ATVBAHA.108.167197.
51. Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, Offenstadt G, Lesèche G, Cohen PL, Tedgui A, Mallat Z, Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 2008 28 1429 1431. doi: 10.1161/ATVBAHA.108.169078.
52. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J, LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003 300 329 332. doi: 10.1126/science.1082095.
53. Overton CD, Yancey PG, Major AS, Linton MF, Fazio S, Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res 2007 100 670 677. doi: 10.1161/01.RES.0000260204.40510.aa.
54. Yancey PG, Blakemore J, Ding L, Fan D, Overton CD, Zhang Y, Linton MF, Fazio S, Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 2010 30 787 795. doi: 10.1161/ATVBAHA.109.202051.
55. Yancey PG, Ding Y, Fan D, Blakemore JL, Zhang Y, Ding L, Zhang J, Linton MF, Fazio S, Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Circulation 2011 124 454 464. doi: 10.1161/CIRCULATIONAHA.111.032268.
56. Zhu L, Giunzioni I, Tavori H, Covarrubias R, Ding L, Zhang Y, Ormseth M, Major AS, Stafford JM, Linton MF, Fazio S, Loss of macrophage low-density lipoprotein receptor-related protein 1 confers resistance to the antiatherogenic effects of tumor necrosis factor- inhibition. Arterioscler Thromb Vasc Biol 2016 36 1483 1495. doi: 10.1161/ATVBAHA.116.307736.
57. Tao H, Yancey PG, Babaev VR, Blakemore JL, Zhang Y, Ding L, Fazio S, Linton MF, Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis. J Lipid Res 2015 56 1449 1460. doi: 10.1194/jlr.M056689.
58. Foks AC, Engelbertsen D, Kuperwaser F, Alberts-Grill N, Gonen A, Witztum JL, Lederer J, Jarolim P, DeKruyff RH, Freeman GJ, Lichtman AH, Blockade of Tim-1 and Tim-4 enhances atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2016 36 456 465. doi: 10.1161/ATVBAHA.115.306860.
59. Bolick DT, Skaflen MD, Johnson LE, Kwon SC, Howatt D, Daugherty A, Ravichandran KS, Hedrick CC, G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ Res 2009 104 318 327. doi: 10.1161/CIRCRESAHA.108.181131.
60. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL, Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A 2004 101 17795 17800. doi: 10.1073/pnas.0408096101.
61. Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, Esposito B, Teissier E, Daemen MJ, Lesèche G, Boulanger C, Tedgui A, Mallat Z, Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 2007 115 2168 2177. doi: 10.1161/CIRCULATIONAHA.106.662080.
62. Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, Boyle JJ, Haskard DO, Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 2007 170 416 426. doi: 10.2353/ajpath.2007.060406.
63. Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, Curtiss LK, Terkeltaub R, Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 2006 26 563 569. doi: 10.1161/01.ATV.0000203503.82693.c1.
64. Lutgens E, Tjwa M, Garcia de Frutos P, Wijnands E, Beckers L, Dahlbäck B, Daemen MJ, Carmeliet P, Moons L, Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol 2008 216 55 63. doi: 10.1002/path.2381.
65. Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP, ApoE-/-Fas-/-C57BL/6 mice: A novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J Lipid Res 2007 48 794 805. doi: 10.1194/jlr.M600512-JLR200.
66. Aprahamian T, Rifkin I, Bonegio R, Hugel B, Freyssinet JM, Sato K, Castellot JJ Jr, Walsh K, Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004 199 1121 1131. doi: 10.1084/jem.20031557.
67. Thorp E, Tabas I, Differential effects of pioglitazone on advanced atherosclerotic lesions. Am J Pathol 2009 175 1348. doi: 10.2353/ajpath.2009.090483.
68. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S, Identification of a factor that links apoptotic cells to phagocytes. Nature 2002 417 182 187. doi: 10.1038/417182a.
69. Tóth B, Garabuczi E, Sarang Z, Vereb G, Vámosi G, Aeschlimann D, Blaskó B, Bécsi B, Erdõdi F, Lacy-Hulbert A, Zhang A, Falasca L, Birge RB, Balajthy Z, Melino G, Fésüs L, Szondy Z, Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 2009 182 2084 2092. doi: 10.4049/jimmunol.0803444.
70. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK, Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001 411 207 211. doi: 10.1038/35075603.
71. Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, Iwata S, Han X, Homma S, Drosatos K, Lomasney J, Engman DM, Miller SD, Vaughan DE, Morrow JP, Kishore R, Thorp EB, Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res 2013 113 1004 1012. doi: 10.1161/CIRCRESAHA.113.301198.
72. Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I, Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ and p38 mitogen-Activated protein kinase (MAPK). J Biol Chem 2011 286 33335 33344. doi: 10.1074/jbc.M111.263020.
73. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE, Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010 24 665 683. doi: 10.1096/fj.09-145482.
74. Boucher P, Herz J, Signaling through LRP1: Protection from atherosclerosis and beyond. Biochem Pharmacol 2011 81 1 5. doi: 10.1016/j.bcp.2010.09.018.
75. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP, Role of CD47 as a marker of self on red blood cells. Science 2000 288 2051 2054
76. Downing KP, Nead KT, Kojima Y, Assimes T, Maegdefessel L, Quertermous T, Cooke JP, Leeper NJ, The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model. Vasc Med 2014 19 3 8. doi: 10.1177/1358863X13514791.
77. Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL, The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A 2012 109 6662 6667. doi: 10.1073/pnas.1121623109.
78. Chao MP, Majeti R, Weissman IL, Programmed cell removal: A new obstacle in the road to developing cancer. Nat Rev Cancer 2011 12 58 67. doi: 10.1038/nrc3171.
79. Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, Ozkan E, Fernhoff NB, van de Rijn M, Weissman IL, Garcia KC, Engineered SIRP variants as immunotherapeutic adjuvants to anticancer antibodies. Science 2013 341 88 91. doi: 10.1126/science.1238856.
80. Liu J, Wang L, Zhao F, Tseng S, Narayanan C, Shura L, Willingham S, Howard M, Prohaska S, Volkmer J, Chao M, Weissman IL, Majeti R, Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLoS One 2015 10 e0137345. doi: 10.1371/journal.pone.0137345.
81. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R, Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010 142 699 713. doi: 10.1016/j.cell.2010.07.044.
82. Greenberg JD, Furer V, Farkouh ME, Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol 2011 8 13 21. doi: 10.1038/nrrheum.2011.168.
83. Antman EM, Loscalzo J, Precision medicine in cardiology. Nat Rev Cardiol 2016 13 591 602. doi: 10.1038/nrcardio.2016.101.
84. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA, Stirrups K, Konig IR, Cazier JB, Johansson A, Hall AS, Lee JY, Willer CJ, Chambers JC, Esko T, Folkersen L, Goel A, Grundberg E, Havulinna AS, Ho WK, Hopewell JC, Eriksson N, Kleber ME, Kristiansson K, Lundmark P, Lyytikainen LP, Rafelt S, Shungin D, Strawbridge RJ, Thorleifsson G, Tikkanen E, Van Zuydam N, Voight BF, Waite LL, Zhang W, Ziegler A, Absher D, Altshuler D, Balmforth AJ, Barroso I, Braund PS, Burgdorf C, Claudi-Boehm S, Cox D, Dimitriou M, Do R, Doney AS, El Mokhtari N, Eriksson P, Fischer K, Fontanillas P, Franco-Cereceda A, Gigante B, Groop L, Gustafsson S, Hager J, Hallmans G, Han BG, Hunt SE, Kang HM, Illig T, Kessler T, Knowles JW, Kolovou G, Kuusisto J, Langenberg C, Langford C, Leander K, Lokki ML, Lundmark A, McCarthy MI, Meisinger C, Melander O, Mihailov E, Maouche S, Morris AD, Muller-Nurasyid M, Nikus K, Peden JF, Rayner NW, Rasheed A, Rosinger S, Rubin D, Rumpf MP, Schafer A, Sivananthan M, Song C, Stewart AF, Tan ST, Thorgeirsson G, van der Schoot CE, Wagner PJ, Wells GA, Wild PS, Yang TP, Amouyel P, Arveiler D, Basart H, Boehnke M, Boerwinkle E, Brambilla P, Cambien F, Cupples AL, de Faire U, Dehghan A, Diemert P, Epstein SE, Evans A, Ferrario MM, Ferrieres J, Gauguier D, Go AS, Goodall AH, Gudnason V, Hazen SL, Holm H, Iribarren C, Jang Y, Kahonen M, Kee F, Kim HS, Klopp N, Koenig W, Kratzer W, Kuulasmaa K, Laakso M, Laaksonen R, Lind L, Ouwehand WH, Parish S, Park JE, Pedersen NL, Peters A, Quertermous T, Rader DJ, Salomaa V, Schadt E, Shah SH, Sinisalo J, Stark K, Stefansson K, Tregouet DA, Virtamo J, Wallentin L, Wareham N, Zimmermann ME, Nieminen MS, Hengstenberg C, Sandhu MS, Pastinen T, Syvanen AC, Hovingh GK, Dedoussis G, Franks PW, Lehtimaki T, Metspalu A, Zalloua PA, Siegbahn A, Schreiber S, Ripatti S, Blankenberg SS, Perola M, Clarke R, Boehm BO, O'Donnell C, Reilly MP, Marz W, Collins R, Kathiresan S, Hamsten A, Kooner JS, Thorsteinsdottir U, Danesh J, Palmer CN, Roberts R, Watkins H, Schunkert H, Samani NJ, Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013 45 25 33.
85. Kullo IJ, Leeper NJ, The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions. Circ Res 2015 116 1551 1560. doi: 10.1161/CIRCRESAHA.116.303518.
86. Wang D, Deuse T, Stubbendorff M, Chernogubova E, Erben RG, Eken SM, Jin H, Li Y, Busch A, Heeger CH, Behnisch B, Reichenspurner H, Robbins RC, Spin JM, Tsao PS, Schrepfer S, Maegdefessel L, Local microRNA modulation using a novel anti-miR-21-eluting stent effectively prevents experimental in-stent restenosis. Arterioscler Thromb Vasc Biol 2015 35 1945 1953. doi: 10.1161/ATVBAHA.115.305597.
87. Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Farokzhad O, Tabas I, Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 2015 7 275ra20. doi: 10.1126/scitranslmed.aaa1065.
88. Benditt EP, Benditt JM, Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 1973 70 1753 1756
89. Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL, Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci U S A 2013 110 3011 3016. doi: 10.1073/pnas.1222861110.
90. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL, CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009 138 271 285. doi: 10.1016/j.cell.2009.05.046.
91. Gomez D, Shankman LS, Nguyen AT, Owens GK, Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 2013 10 171 177. doi: 10.1038/nmeth.2332.
92. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, Owens GK, KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 2015 21 628 637. doi: 10.1038/nm.3866.
93. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM, Fisher EA, Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol 2015 35 535 546. doi: 10.1161/ATVBAHA.114.304029.
94. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN, Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007 37 748 755. doi: 10.1165/rcmb.2007-0025OC.
95. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW, Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 2006 176 7657 7665
96. Isenberg JS, Hyodo F, Pappan LK, Abu-Asab M, Tsokos M, Krishna MC, Frazier WA, Roberts DD, Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 2007 27 2582 2588. doi: 10.1161/ATVBAHA.107.155390.
97. Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL, PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood 2010 116 4512 4522. doi: 10.1182/blood-2010-02-272005.
98. Karunakaran D, Geoffrion M, Wei L, Gan W, Richards L, Shangari P, DeKemp EM, Beanlands RA, Perisic L, Maegdefessel L, Hedin U, Sad S, Guo L, Kolodgie FD, Virmani R, Ruddy T, Rayner KJ, Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv 2016 2 e1600224. doi: 10.1126/sciadv.1600224.
99. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I, Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012 15 545 553. doi: 10.1016/j.cmet.2012.01.022.
100. Sidney S, Quesenberry CP Jr, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, Go AS, Rana JS, Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol 2016 1 594 599. doi: 10.1001/jamacardio.2016.1326.